Several studies have confirmed that ARHGEF11 affects the metabolism of glucose and fatty acids through the insulin signaling pathway and acts as a key determinant of metabolism- and obesity-associated pathologies [16–18]. Here, ARHGEF11 is linked to obesity disorder.